SnagRx vs Willow: $69 Compounded vs $299 Oral GLP-1
Quick verdict: SnagRx is a lower-cost compounded semaglutide program with a price lock on a 12-month plan and named US 503A pharmacies; Willow is a telehealth-first oral GLP-1 program priced at $299 that emphasizes progress tracking and follow-up support. Choose based on whether you prioritize predictable compounded pricing or integrated behavioral follow-up.
See SnagRx $69/mo semaglutide plan
SnagRx vs Willow: pricing, medication form, clinician model, support
In direct comparison, SnagRx and Willow differ most clearly on five points: price and billing terms, medication format and regulatory notes, named pharmacy and clinician details, follow-up and coaching, and shipping or workflow features. Below I compare those differences using only the supplied facts.
1) Price and billing terms
SnagRx advertises compounded semaglutide from $69/month and tirzepatide from $119/month on a 12-month plan. Those figures are explicitly the 12-month plan rates; month-to-month equivalents are $99 and $149. SnagRx states the rate is locked flat at every dose for the life of treatment. Willow is presented with a $299 starting price for its oral GLP-1 program. The evidence notes Willow has higher monthly entry pricing for some plans but provides no tier breakdown. If predictable, locked-in compounded pricing matters, that is SnagRx’s stated differentiator.
Compare SnagRx pricing and price lock
2) Medication form and regulatory notes
SnagRx offers compounded semaglutide and compounded tirzepatide. The source states compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. SnagRx names its four US 503A partner pharmacies. Willow focuses on an oral GLP-1 program. The captured Willow page notes that medication-specific approval status must be confirmed and that branded and compounded products are not interchangeable. Both providers therefore present approaches where approval and product type vary; the sources caution that compounded medications are not FDA-approved.
3) Clinician network and telehealth workflow
SnagRx says medical care is delivered by OpenLoop Health, a network of US-licensed clinicians covering 48 states, and that an OpenLoop clinician typically reviews intake within five hours and always within 24. Willow positions a licensed telehealth team and a telehealth-first workflow; its emphasis is on follow-up and structured support, with treatment available only when a licensed clinician determines it is medically appropriate. SnagRx names its clinician network; Willow highlights licensed clinicians and follow-up but the captured page did not name partners.
Explore Willow oral GLP-1 program
4) Follow-up, tracking and coaching
Willow is described as a structured weight management journey that emphasizes progress tracking and follow-up support, designed for users who want behavioral scaffolding alongside medication. SnagRx does not provide coaching or nutrition programming according to the captured evidence; its focus is medication, clinician review, named pharmacies, shipping and a pricing guarantee. If progress tracking and follow-up consultations are a priority, the supplied facts favor Willow. If a low-cost compounded medication with clinician review and fast shipping is the priority, SnagRx is the stated option.
5) Shipping, turnaround and guarantees
SnagRx states next-day UPS or FedEx shipping in temperature-controlled packaging, clinician review typically within five hours, and a full refund if a prescription is declined. SnagRx also cites a six-month weight-loss guarantee with terms. Willow’s captured page did not verify shipping, fees, membership or cancellation details, only that it offers a simple digital workflow and follow-up. The only shipping and refund specifics in the sources belong to SnagRx.
| Criteria | SnagRx | Willow |
|---|---|---|
| Starting price | From $69/month semaglutide on 12-month plan (month-to-month $99) | $299 starting price |
| Medication format | Compounded semaglutide and tirzepatide (503A pharmacies) | Oral GLP-1 program; medication-specific approval status must be confirmed |
| Price model | Price locked flat at every dose for life on plan | Higher monthly entry pricing for some plans; structure emphasizes program |
| Clinician model | OpenLoop Health network, clinician review typically within 5 hours (48 states) | Licensed telehealth team with follow-up consultations; treatment subject to clinician determination |
| Support and coaching | No coaching or nutrition programming captured | Progress tracking tools and follow-up support emphasized |
| Shipping and turnaround | Next-day UPS/FedEx, temperature-controlled packaging; refund if prescription declined | Captured page did not verify shipping or fees |
What the comparison does not supply
The captured evidence does not provide full plan tiers for Willow, membership terms for Willow, or comprehensive state eligibility lists beyond SnagRx’s clinician network covering 48 states. Efficacy, insurance coverage, specific medication brands, or long-term outcomes are not supplied and are therefore not addressed here.
Get details on SnagRx compounded plans
View Willow program and tracking features
Conclusion: Choose based on price predictability versus structured follow-up
SnagRx vs Willow breaks down to a choice between a low-cost, price-locked compounded semaglutide program with named US 503A pharmacies, next-day shipping and a clinician network (SnagRx), and a telehealth-first oral GLP-1 program priced at $299 that prioritizes progress tracking and follow-up support (Willow). Both note clinician review and that medication approval status differs by product type. Choose SnagRx if you want predictable compounded pricing and named pharmacy partners. Choose Willow if you prioritize structured digital follow-up and progress tracking.
Choose SnagRx if you need predictable, price-locked compounded semaglutide and named pharmacy and clinician details. Choose Willow if you want a telehealth-first oral GLP-1 program with progress tracking and follow-up.